The current economic burden of cirrhosis.
Guy Neff, Christopher W. Duncan, Eugene R. Schiff
Europe PMC (PubMed Central), 2011
Abstract
This research paper explore the methodology and findings associated with Europe PMC (PubMed Central). The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
Related Research
- Role of 6‐month abstinence rule in living donor liver transplantation for patients with alcoholic liver disease 2013
- Perceptions of post-transplant recidivism in liver transplantation for alcoholic liver disease 2014
- Lasting nutritional imbalance following abstinence in patients with alcoholic cirrhosis. 1989
- Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients 2015
- Perceptions of post-transplant recidivism in liver transplantation for alcoholic liver disease 2014
References
- Alcoholics Anonymous and other 12-step programmes for alcohol dependence 2006
- Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. 2006
- A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels. 2007
- Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low? 2009
- A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents 2005